BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 30772304)

  • 1. Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study.
    Cheung CL; Tan KCB; Au PCM; Li GHY; Cheung BMY
    EBioMedicine; 2019 Mar; 41():85-90. PubMed ID: 30772304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically Higher Level of Mannose Has No Impact on Cardiometabolic Risk Factors: Insight from Mendelian Randomization.
    Mazidi M; Dehghan A; Banach M; On Behalf Of The Lipid And Blood Pressure Meta-Analysis Collaboration Lbpmc Group And The International Lipid Expert Panel Ilep
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444725
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
    Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the causal effect of fibroblast growth factor 23 on osteoporosis and cardiometabolic disorders: A Mendelian randomization study.
    Yokomoto-Umakoshi M; Umakoshi H; Miyazawa T; Ogata M; Sakamoto R; Ogawa Y
    Bone; 2021 Feb; 143():115777. PubMed ID: 33253933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
    Au Yeung SL; Luo S; Schooling CM
    Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic Polygenic Risk Scores and Osteoarthritis Outcomes: A Mendelian Randomization Study Using Data From the Malmö Diet and Cancer Study and the UK Biobank.
    Hindy G; Åkesson KE; Melander O; Aragam KG; Haas ME; Nilsson PM; Kadam UT; Orho-Melander M
    Arthritis Rheumatol; 2019 Jun; 71(6):925-934. PubMed ID: 30615301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are serum concentrations of vitamin B-12 causally related to cardiometabolic risk factors and disease? A Mendelian randomization study.
    Moen GH; Qvigstad E; Birkeland KI; Evans DM; Sommer C
    Am J Clin Nutr; 2018 Aug; 108(2):398-404. PubMed ID: 29982347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans.
    Lemmelä S; Wigmore EM; Benner C; Havulinna AS; Ong RMY; Kempf T; Wollert KC; Blankenberg S; Zeller T; Peters JE; Salomaa V; Fritsch M; March R; Palotie A; Daly M; Butterworth AS; Kinnunen M; Paul DS; Matakidou A
    Elife; 2022 Aug; 11():. PubMed ID: 35916366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using multivariable Mendelian randomization to estimate the causal effect of bone mineral density on osteoarthritis risk, independently of body mass index.
    Hartley A; Sanderson E; Granell R; Paternoster L; Zheng J; Smith GD; Southam L; Hatzikotoulas K; Boer CG; van Meurs J; Zeggini E; ; Gregson CL; Tobias JH
    Int J Epidemiol; 2022 Aug; 51(4):1254-1267. PubMed ID: 34897459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal Associations of Anthropometric Measurements With Fracture Risk and Bone Mineral Density: A Mendelian Randomization Study.
    Ma B; Li C; Pan J; Zhang S; Dong H; Wu Y; Lv J
    J Bone Miner Res; 2021 Jul; 36(7):1281-1287. PubMed ID: 33784428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
    Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
    Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
    Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
    Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
    Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
    Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
    Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
    Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically Predicted Insomnia in Relation to 14 Cardiovascular Conditions and 17 Cardiometabolic Risk Factors: A Mendelian Randomization Study.
    Liu X; Li C; Sun X; Yu Y; Si S; Hou L; Yan R; Yu Y; Li M; Li H; Xue F
    J Am Heart Assoc; 2021 Aug; 10(15):e020187. PubMed ID: 34315237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study.
    He L; Culminskaya I; Loika Y; Arbeev KG; Bagley O; Duan M; Yashin AI; Kulminski AM
    Exp Gerontol; 2018 Jul; 107():74-86. PubMed ID: 28964830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study.
    Cao M; Cui B
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31614369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.
    Wang D; Day EA; Townsend LK; Djordjevic D; Jørgensen SB; Steinberg GR
    Nat Rev Endocrinol; 2021 Oct; 17(10):592-607. PubMed ID: 34381196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Function and Metabolic Syndrome: A Two-Sample Bidirectional Mendelian Randomization Study.
    Pleić N; Gunjača I; Babić Leko M; Zemunik T
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3190-3200. PubMed ID: 37339283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic correlates of growth differentiation factor 15 in the community.
    Ho JE; Mahajan A; Chen MH; Larson MG; McCabe EL; Ghorbani A; Cheng S; Johnson AD; Lindgren CM; Kempf T; Lind L; Ingelsson E; Vasan RS; Januzzi J; Wollert KC; Morris AP; Wang TJ
    Clin Chem; 2012 Nov; 58(11):1582-91. PubMed ID: 22997280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.